Radiopharm Theranostics Ltd Cash Flow-to-Debt Ratio
Radiopharm Theranostics Ltd cash flow-to-debt ratio. Radiopharm Theranostics Ltd (RAD) has a Cash Flow-to-Debt Ratio of -0.80x as of June 2026, meaning its operating cash flow of AU$-30.11 Million could theoretically repay -1% of its total liabilities (AU$37.81 Million) in one year. See how financially flexible is Radiopharm Theranostics Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Radiopharm Theranostics Ltd (2021–2026)
Cash flow-to-debt ratio of Radiopharm Theranostics Ltd from 2021 to 2026. Historical debt coverage capacity for Radiopharm Theranostics Ltd across 6 annual periods. Also explore RAD net asset momentum to track the company's year-over-year net asset growth rate.
Radiopharm Theranostics Ltd Cash Flow-to-Debt Ratio by Year (2021–2026)
Radiopharm Theranostics Ltd cash flow-to-debt ratio by year from 2021 to 2026. Year-by-year debt coverage analysis for Radiopharm Theranostics Ltd. For the full cash flow conversion analysis, see Radiopharm Theranostics Ltd cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -1.40x | AU$-52.78 Million | AU$37.81 Million | ▼ -66.1% |
| 2025 | -0.84x | AU$-36.65 Million | AU$43.61 Million | ▼ -63.4% |
| 2024 | -0.51x | AU$-22.98 Million | AU$44.68 Million | ▲ +34.9% |
| 2023 | -0.79x | AU$-23.20 Million | AU$29.37 Million | ▼ -62.8% |
| 2022 | -0.49x | AU$-9.91 Million | AU$20.42 Million | ▼ -133.2% |
| 2021 | -0.21x | AU$-32.91K | AU$158.14K | — |